Aardvark Therapeutics
AARD
#7681
Rank
$0.29 B
Marketcap
$13.74
Share price
-20.35%
Change (1 day)
N/A
Change (1 year)

Aardvark Therapeutics (AARD) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $0.12 Billion USD

According to Aardvark Therapeutics's latest financial reports the company's total liabilities are $0.12 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aardvark Therapeutics - Total liabilities on balance sheet (from 2023 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$45.33 M1.47%
2022-12-31$44.68 M